The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 16, 2012

Filed:

Sep. 30, 2009
Applicants:

Markus Henrich, Munzenberg, DE;

Angela Bauer, Mainz, DE;

Jens Nagel, Blankensee, DE;

Meik Sladek, Bad Soden-Salmünster, DE;

Christopher Graham Raphael Parsons, Nidderau, DE;

Wojciech Danysz, Nidderau, DE;

Valerjans Kauss, Rigariga, LV;

Jevgenijs Rozhkovs, Riga, LV;

Igors Starchenkovs, Riga, LV;

Dina Trifanova, Riga, LV;

Inventors:

Markus Henrich, Munzenberg, DE;

Angela Bauer, Mainz, DE;

Jens Nagel, Blankensee, DE;

Meik Sladek, Bad Soden-Salmünster, DE;

Christopher Graham Raphael Parsons, Nidderau, DE;

Wojciech Danysz, Nidderau, DE;

Valerjans Kauss, Rigariga, LV;

Jevgenijs Rozhkovs, Riga, LV;

Igors Starchenkovs, Riga, LV;

Dina Trifanova, Riga, LV;

Assignee:

Merz Pharma GmbH & Co. KGaA, Frankfurt am Main, DE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 215/54 (2006.01); C07D 401/12 (2006.01); C07D 409/12 (2006.01); C07D 409/14 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention relates to quinoline derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonists and are therefore useful for the control and prevention of various disorders, including neurological disorders.


Find Patent Forward Citations

Loading…